Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

2018 US Device Approvals: The Year Of De Novos And Digital Health

Jan 14 2019

• By David Filmore

FDA approved background, 3D rendering, blue street sign

Related Content

Dexcom Gains Approval For No-Calibration, 'Interoperable' CGM System

Mar 27 2018

Good News For Senseonics, Medtronic Diabetes Devices

Jun 25 2018

US Approvals Analysis: Hits Just Keep On Coming. Can It Last?

Jan 17 2018

US FDA Implements 'Firm-Based' Regulatory Approach To DTC Genetic Health Risk Tests

Nov 07 2017

2019 Will Be Testing Period For US FDA's Novel Pre-Cert Paradigm For Digital Health

Jan 08 2019

Gottlieb Takes To Twitter To Raise FDA Morale Amid Shutdown

Jan 04 2019

As US FDA Shutdown Continues, What Will Be The Cost Of Not Spending?

Jan 02 2019

Successful De Novo Petitions Double With Advent Of Direct Route

Oct 28 2014

Minding The Middle: FDA Fleshes Out De Novo Regs As The Program Expands

Dec 04 2018

Related Companies

23andMe, Inc.

Edwards Lifesciences Corp.

DreaMed Diabetes, Ltd.

Abbott

Medtronic plc

Senseonics Holdings, Inc.

Tandem Diabetes Care, Inc.

DexCom, Inc.

Terumo Corporation

Stryker Corporation

Cala Health, Inc.

BrainsWay Ltd.

Glaukos Corporation

Ivantis, Inc.

Additional Topics

United States Approvals FDA Digital Health Research & Development Medical Device In Vitro Diagnostics

More from Approvals

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Medtech Top 100 Ranking
Data Trackers
FDA Warning Letters

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window